• 8473 Citations
  • 41 h-Index
1981 …2019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1981 2019

  • 8473 Citations
  • 41 h-Index
  • 171 Article
  • 8 Review article
  • 1 Letter
  • 1 Short survey
Filter
Review article
2019
7 Citations (Scopus)

Therapeutic Drug Monitoring in Oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology Recommendations for 5-Fluorouracil Therapy

Beumer, J. H., Chu, E., Allegra, C., Tanigawara, Y., Milano, G., Diasio, R., Kim, T. W., Mathijssen, R. H., Zhang, L., Arnold, D., Muneoka, K., Boku, N. & Joerger, M., Mar 1 2019, In : Clinical pharmacology and therapeutics. 105, 3, p. 598-613 16 p.

Research output: Contribution to journalReview article

Drug Monitoring
Fluorouracil
Toxicology
Body Surface Area
Head and Neck Neoplasms
2015

Pharmacokinetic issues on cancer pharmacotherapy

Tanigawara, Y., Aug 1 2015, In : Nihon rinsho. Japanese journal of clinical medicine. 73, 8, p. 1357-1363 7 p.

Research output: Contribution to journalReview article

Pharmacokinetics
Drug Therapy
Drug Delivery Systems
Pharmaceutical Preparations
Neoplasms
42 Citations (Scopus)

Pharmacokinetics, dynamics and toxicity of docetaxel: Why the Japanese dose differs from the Western dose

Kenmotsu, H. & Tanigawara, Y., May 1 2015, In : Cancer science. 106, 5, p. 497-504 8 p.

Research output: Contribution to journalReview article

docetaxel
Pharmacokinetics
Area Under Curve
Japan
Population

The survey for anti-emetic guideline by using questioner

Saeki, T., Tamura, K., Aiba, K., Aogi, K., Lino, K., Imamura, C., Eguchi, K., Okita, K., Kagami, Y., Tanaka, R., Nakagawa, K., Fujii, H., Boku, N., Matsuura, K., Wada, M., Akechi, T., Kakudo, Y., Kim, Y. I., Sasaki, H. N., Shima, Y. & 9 others, Takeda, M., Nagasaki, E., Nishidate, T., Saito, M., Ashikaga, Y., Tanigawara, Y., Hirata, K., Ishioka, C. & Nishiyama, M., Mar 1 2015, In : Japanese Journal of Cancer and Chemotherapy. 42, 3, p. 305-311 7 p.

Research output: Contribution to journalReview article

Antiemetics
Guidelines
Japan
Medical Oncology
Therapeutics
2011
11 Citations (Scopus)

Overview of the clinical pharmacokinetics of eldecalcitol, a new active vitamin D3 derivative

Abe, M., Tsuji, N., Takahashi, F. & Tanigawara, Y., Mar 2011, In : Japanese Pharmacology and Therapeutics. 39, 3, p. 261-274 14 p.

Research output: Contribution to journalReview article

Cholecalciferol
Pharmacokinetics
Clinical Pharmacology
Therapeutic Equivalency
Drug Interactions
2005
25 Citations (Scopus)

Cancer pharmacogenomics: International trends

Yamayoshi, Y., Iida, E. & Tanigawara, Y., Feb 1 2005, In : International Journal of Clinical Oncology. 10, 1, p. 5-13 9 p.

Research output: Contribution to journalReview article

Pharmacogenetics
Pharmaceutical Preparations
Neoplasms
DNA Repair Enzymes
Therapeutic Uses

Overview: Pharmacokinetics/pharmacodynamics (PK/PD) of antimicrobial agents

Tanigawara, Y., Jul 2005, In : Japanese Journal of Clinical Pharmacology and Therapeutics. 36, 4, p. 166-172 7 p.

Research output: Contribution to journalReview article

Anti-Infective Agents
Pharmacokinetics
2002
1 Citation (Scopus)

Variability in drug response caused by the genetic polymorphisms of receptors

Tanigawara, Y., Iketani, O. & Yamayoshi, Y., Jan 1 2002, In : Nippon rinsho. Japanese journal of clinical medicine. 60, 1, p. 51-57 7 p.

Research output: Contribution to journalReview article

Genetic Polymorphisms
Calcitriol Receptors
PPAR gamma
Vitamin D
Pharmaceutical Preparations